| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.27▲ | 4.29▲ | 4.31▼ | 4.39▼ | 4.92▼ |
| MA10 | 4.27▲ | 4.30▼ | 4.27▲ | 4.66▼ | 4.15▲ |
| MA20 | 4.29▲ | 4.26▲ | 4.29▼ | 4.96▼ | 4.64▼ |
| MA50 | 4.27▲ | 4.40▼ | 4.52▼ | 4.13▲ | N/A |
| MA100 | 4.35▼ | 4.64▼ | 4.94▼ | 4.78▼ | N/A |
| MA200 | 4.55▼ | 5.00▼ | 4.71▼ | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | 0.014▲ | 0.025▲ | -0.154▼ | 0.102▲ |
| RSI | 52.814▲ | 47.989▼ | 44.618▼ | 43.591▼ | 43.356▼ |
| STOCH | 59.524 | 57.026 | 69.318 | 7.674▼ | 50.224 |
| WILL %R | -42.857 | -36.364 | -36.364 | -90.109▼ | -62.500 |
| CCI | 89.764 | 18.338 | 31.955 | -108.495▼ | 3.477 |
|
Thursday, September 23, 2021 09:28 AM
Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing, including mild ...
|
|
Thursday, September 23, 2021 04:30 AM
Drs. Clete Kushida of Stanford and Cecilia Wu of University of Alberta to lead a team of prominent, multi-disciplinary medical doctors guiding research and fostering increased physician-dental ...
|
|
Wednesday, September 22, 2021 11:44 PM
Vivos Therapeutics (NASDAQ: VVOS) , a medical technology company focused on developing and commercializing innovative treatments for patients suffer ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 23/09/21 | 4.21 | 4.37 | 4.16 | 4.29 | 236,904 |
| 22/09/21 | 4.32 | 4.36 | 4.12 | 4.29 | 379,094 |
| 21/09/21 | 4.41 | 4.57 | 4.26 | 4.29 | 177,699 |
| 20/09/21 | 4.51 | 4.83 | 4.32 | 4.38 | 786,961 |
| 17/09/21 | 4.63 | 4.96 | 4.6001 | 4.69 | 703,636 |
| 16/09/21 | 4.75 | 4.80 | 4.56 | 4.65 | 178,711 |
| 15/09/21 | 4.77 | 4.95 | 4.68 | 4.73 | 205,340 |
| 14/09/21 | 5.30 | 5.35 | 4.63 | 4.84 | 577,189 |
| 13/09/21 | 5.35 | 5.46 | 5.16 | 5.19 | 476,453 |
| 10/09/21 | 5.49 | 5.77 | 5.03 | 5.26 | 835,918 |
|
|
||||
|
|
||||
|
|